Artificial intelligence | Pharmaceuticals | Regulatory Rapporteur

Skip to main content
Skip to navigation

Artificial intelligence articles

MD7: Updates on Artificial Intelligence legislation and policy

2025-11-18T10:07:00+00:00By Hasnaa Fatehi

This is a report of the MD7 session that took place at this year’s Symposium.

MD6: The importance of digital health – Digital Health Applications (DiGA) and the Digital Mental Health Technology Project
2025-11-18T10:06:00+00:00By Steve Lee
MD5: The evolution of the EU Medical Device Regulation
2025-11-18T10:06:00+00:00By Célia Cruz
HM4: Revision of the EU Variation Regulation – Continuing innovation in lifecycle management
2025-11-18T09:55:00+00:00By Jessica Roe
HM3: Applying Artificial Intelligence in real life
2025-11-18T09:44:00+00:00By Natasha Bankowski
HM2: Fireside chat
2025-11-18T09:44:00+00:00By Cristina Dragan
HM1: General pharmaceutical legislation - Platform technology and sandbox approaches
2025-11-18T09:44:00+00:00By Dr Evyenia Shaili

HM6: How Artificial Intelligence is transforming regulatory approaches towards chemistry, manufacturing and controls (CMC)
2025-11-13T14:35:00+00:00By Francisco Baptista
Digital transformation of global regulatory affairs: Then, now and next
2025-09-05T09:10:00+01:00By Craig Anderson and Michael J Abernathy
Sandbox of trust: Regulated AI for health promotion and disease prevention
2025-06-06T14:07:00+01:00By Catarina Carrão
Prescribing efficiency: Using generative artificial intelligence for pharmacovigilance
2025-05-02T13:42:00+01:00By Ihab Mansoor and Matthew Rector
The role of artificial intelligence in regulatory affairs
2025-01-10T08:54:00+00:00By Rudy Fuentes, Sean Schofield and Lubomir Zahariev
MD2/IVD2: Unravelling AI as a medical device - Insights into the EU AI Act and other global perspectives
2024-11-08T06:56:00+00:00By Margareth Jorvid

More AI stories